Cargando…

The effects of physical exercise on cardiometabolic outcomes in women with polycystic ovary syndrome not taking the oral contraceptive pill: a systematic review and meta-analysis

PURPOSE: Women with polycystic ovary syndrome (PCOS) exhibit many metabolic abnormalities that are associated with an increased cardiovascular disease risk. Exercise may promote improvements in lipid profile and insulin sensitivity in women with PCOS. There is however, a knowledge gap on the optimal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Woodward, Amie, Broom, David, Harrop, Deborah, Lahart, Ian, Carter, Anouska, Dalton, Caroline, Metwally, Mostafa, Klonizakis, Markos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2019
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6915192/ https://www.ncbi.nlm.nih.gov/pubmed/31890686 http://dx.doi.org/10.1007/s40200-019-00425-y

Ejemplares similares

The effects of exercise on cardiometabolic outcomes in women with polycystic ovary syndrome not taking the oral contraceptive pill: protocol for a systematic review and meta-analysis
por: Woodward, Amie, et al.
Publicado: (2019)

Supervised exercise training and increased physical activity to reduce cardiovascular disease risk in women with polycystic ovary syndrome: study protocol for a randomized controlled feasibility trial
por: Woodward, Amie, et al.
Publicado: (2020)

First intention IVF protocol for polycystic ovaries: does oral contraceptive pill pretreatment influence COH outcome?
por: Decanter, Christine, et al.
Publicado: (2013)

Exercise, or exercise and diet for the management of polycystic ovary syndrome: a systematic review and meta-analysis
por: Kite, Chris, et al.
Publicado: (2019)

Cardiometabolic risk in polycystic ovary syndrome
por: Bajuk Studen, Katica, et al.
Publicado: (2018)

An Update on Contraception in Polycystic Ovary Syndrome
por: Oguz, Seda Hanife, et al.
Publicado: (2021)

The Association Between Cardiovascular Function, Measured as FMD and CVC, and Long-Term Aquatic Exercise in Older Adults (ACELA Study): A Cross-Sectional Study
por: Klonizakis, Markos, et al.
Publicado: (2020)

THE CONTRACEPTIVE PILL
Publicado: (1965)

Oral contraceptive pills induced hemichorea in an adolescent female with polycystic ovarian disease
por: Sharmila, Vijayan, et al.
Publicado: (2015)

Deep vein thrombosis in a woman taking oral combined contraceptive pills
por: Piparva, Kiran G., et al.
Publicado: (2011)

Consensus Statement on the Use of Oral Contraceptive Pills in Polycystic Ovarian Syndrome Women in India
por: Shah, Duru, et al.
Publicado: (2018)

Long-Lasting Androgen-Induced Cardiometabolic Effects in Polycystic Ovary Syndrome
por: Torres Fernandez, Edgar D, et al.
Publicado: (2018)

Efficacy and safety of metformin or oral contraceptives, or both in polycystic ovary syndrome
por: Yang, Young-Mo, et al.
Publicado: (2015)

Contraception for Women with Polycystic Ovary Syndrome: Dealing with a Complex Condition
por: Spritzer, Poli Mara
Publicado: (2022)

Cardiometabolic Effects of Cabergoline and Combined Oral Contraceptive Pills in Young Women with Hyperprolactinemia: A Pilot Study
por: Krysiak, Robert, et al.
Publicado: (2023)

Effect of six-month use of oral contraceptive pills on plasminogen activator inhibitor-1 & factor VIII among women with polycystic ovary syndrome: An observational pilot study
por: Yousuf, Syed Douhath, et al.
Publicado: (2018)

Spironolactone Versus Oral Contraceptive Pills in the Treatment of Adolescent Polycystic Ovarian Syndrome: A Systematic Review
por: Rajashekar, Shriya, et al.
Publicado: (2022)

The impact of atorvastatin on cardiometabolic risk factors in brothers of women with polycystic ovary syndrome
por: Krysiak, Robert, et al.
Publicado: (2020)

Hormonal contraception in women with polycystic ovary syndrome: choices, challenges, and noncontraceptive benefits
por: de Melo, Anderson Sanches, et al.
Publicado: (2017)

Comparative Perceptual, Affective, and Cardiovascular Responses between Resistance Exercise with and without Blood Flow Restriction in Older Adults
por: Parkington, Thomas, et al.
Publicado: (2022)

Dingkun pill alleviates metabolic abnormalities in polycystic ovary syndrome through brown adipose tissue activation
por: Gu, Mengqing, et al.
Publicado: (2023)

Influence of combined oral contraceptives on polycystic ovarian morphology-related parameters in Korean women with polycystic ovary syndrome
por: Park, Chan-Hong, et al.
Publicado: (2020)

A randomized, controlled trial comparing the metformin, oral contraceptive pills and their combination in patients with polycystic ovarian syndrome
por: Kumar, Yogesh, et al.
Publicado: (2018)

Polycystic Ovary Syndrome: Important Underrecognised Cardiometabolic Risk Factor in Reproductive-Age Women
por: Baldani, Dinka Pavicic, et al.
Publicado: (2015)

Correction to: The impact of atorvastatin on cardiometabolic risk factors in brothers of women with polycystic ovary syndrome
por: Krysiak, Robert, et al.
Publicado: (2021)

Change in Androgenic Status and Cardiometabolic Profile of Middle-Aged Women with Polycystic Ovary Syndrome
por: van der Ham, Kim, et al.
Publicado: (2023)

Investigation of the Mechanism of Zishen Yutai Pills on Polycystic Ovary Syndrome: A Network Pharmacology and Molecular Docking Approach
por: Chen, Yingyin, et al.
Publicado: (2021)

Improving combined contraceptive pill/oral contraceptives prescribing in general practice
por: Russell, Sophie, et al.
Publicado: (2017)

A Comparative Study of Luteinizing Hormone Levels in Polycystic Ovarian Syndrome With Hyperandrogenism: Metformin Versus Oral Contraceptive Pills
por: Fattah, Abdul, et al.
Publicado: (2022)

Renal infarction due to oral contraceptive pills
por: Guditi, Swarnalatha, et al.
Publicado: (2012)

Clinical Pharmacology of Hormonal Emergency Contraceptive Pills
por: Matyanga, Celia M. J., et al.
Publicado: (2018)

Low-intensity resistance exercise with blood flow restriction for patients with claudication: A randomized controlled feasibility trial
por: Parkington, Thomas, et al.
Publicado: (2023)

Visceral Adiposity Index: Simple Tool for Assessing Cardiometabolic Risk in Women with Polycystic Ovary Syndrome
por: Agrawal, Hiya, et al.
Publicado: (2019)

ApoB48-Lipoproteins Are Associated with Cardiometabolic Risk in Adolescents with and without Polycystic Ovary Syndrome
por: Vine, Donna F, et al.
Publicado: (2020)

Impact of SGLT-2 Inhibition on Cardiometabolic Abnormalities in a Rat Model of Polycystic Ovary Syndrome
por: Pruett, Jacob E., et al.
Publicado: (2021)

The Role of Different Methods in Defining Cardiometabolic Risk and Metabolic Syndrome in Women with Polycystic Ovary Syndrome
por: Çakır Biçer, Nihan, et al.
Publicado: (2023)

Effect of oral contraceptives and/or metformin on GLP-1 secretion and reactive hypoglycaemia in polycystic ovary syndrome
por: Glintborg, Dorte, et al.
Publicado: (2017)

Endocrine Risk Factors of Endometrial Cancer: Polycystic Ovary Syndrome, Oral Contraceptives, Infertility, Tamoxifen
por: Ignatov, Atanas, et al.
Publicado: (2020)

Efficacy of a combined contraceptive regimen consisting of condoms and emergency contraception pills
por: Zhao, Rui, et al.
Publicado: (2014)

Effect of the Monthly Injectable Combined Contraceptives versus Oral Contraceptive Pills on Mood
por: Khafagy, Ghada M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qdsi85rfb09ria7jgrfuvb9ljp